Burmeister T, Stroh AS, Kehden B, Trautmann H, et al. Measurable residual disease quantification in adult patients with KMT2A-rearranged acute lymphoblastic leukemia. Leukemia 2024 Mar 22. doi: 10.1038/s41375-024-02209.
PMID: 38519799